Bard Peripheral Vascular, Inc.
1625 W 3rd St, TEMPE, AZ, US
Registered product codes
48 product codes
Recent MDR events
38,072 on file
- ConquestJul 31, 2026Malfunction2020394-2026-01973
- ConquestJul 31, 2026Malfunction2020394-2026-01974
- Ultraverse RXJul 31, 2026Malfunction2020394-2026-01975
- MaxcoreJul 31, 2026Malfunction2020394-2026-01976
- MaxcoreJul 31, 2026Malfunction2020394-2026-01978
- MaxcoreJul 31, 2026Malfunction2020394-2026-01977
- GhiatasJul 31, 2026Malfunction2020394-2026-01979
- Atlas GoldJul 31, 2026Malfunction2020394-2026-01980
- AtlasJul 30, 2026Malfunction2020394-2026-01962
- VaccessJul 30, 2026Malfunction2020394-2026-01961
Recalls
235 on file
- Open, ClassifiedFeb 13, 2026
Due to damage to outer tray that can potentially compromise the sterile barrier
View FDA record ↗ - Open, ClassifiedDec 5, 2025
Acute drainage catheters, indicated for use in removing fluid during acute drainage/aspiration procedure, manufactured with safety indicators that erroneously show catheter in sharp position when catheter is in blunt position, which may lead users to believe device is not yet in pleural or peritoneal space when it is, may cause discomfort, delay to treatment, injury to internal organs or vessels.
View FDA record ↗ - Open, ClassifiedSep 26, 2025
Software version 3.35 of the Venclose digiRF Generator incorporates a catheter verification feature specifically designed to detect internal wiring anomalies in Venclose EVSRF Ablation Catheters prior to clinical use. This automated diagnostic check is executed immediately upon catheter connection to the generator, occurring before the procedure interface becomes accessible. When a catheter fails this verification process, the generator displays a Red X indicator on the screen without accompanying error codes, effectively disabling catheter functionality. However, BD has determined that software version 3.35 generates false positive failures due to temperature-dependent verification parameters, incorrectly flagging properly functioning Venclose EVSRF Ablation Catheters as defective when the catheter temperature is not at steady state during the check initiation.
View FDA record ↗ - Open, ClassifiedMar 5, 2025
Atherectomy Catheter eIFU updated to clarify and emphasize procedural steps intended to reduce the likelihood of catheter breakage events. Catheter has an outer cylinder connected to a rotating helix, which could fracture and/or break, which would require retrieval, and helix facture/break could cause vessel injury and lead to severe bleeding.
View FDA record ↗ - Open, ClassifiedNov 15, 2024
Disposable biopsy instruments were potentially manufactured missing the backend notch retention feature on the needle that results in inadequate securing of the needle inside the device, which could lead to needle detachment and misplacement, which could lead to tissue damage and bleeding.
View FDA record ↗ - Open, ClassifiedNov 13, 2024
The Venclose" RF Ablation Catheters may have been manufactured with internal wiring error. The red and yellow signal wires were soldered on swapped ports of the catheter PCB. This error in wire configuration would lead to power being applied through the proximal 3/4th of the heating coil, bypassing the thermocouple, which will then cause the generator to overdrive the catheter in an attempt to reach desired temperature set point. The wire attachment error causes the device to reach temperatures exceeding the levels intended for therapeutic efficacy, while the console is falsely indicating that temperature has not yet been reached, thus increasing the risk of harm due to excessive temperature.
View FDA record ↗ - Open, ClassifiedSep 20, 2024
Due to possible packaging damage (indentations/cuts) cause by manufacturing process. As a result of the packaging damage, may cause the sterile barrier to be compromised.
View FDA record ↗ - Open, ClassifiedSep 6, 2024
Due to guidewires being manufactured incorrectly with the guidewires being mis-assembled within the hoop such that the proximal (stiff) end of the guidewire is located at the distal end of the hoop. Injury could occur if the user attempts to insert the proximal end into the patient.
View FDA record ↗ - Open, ClassifiedJan 5, 2024
The internal diameter of the coaxial cannula may be smaller or larger than the external diameter of the biopsy needle, and the length of the cannula may exceed the stated length on the label. As a result, the biopsy needle may not fit properly into the coaxial cannula, preventing access to the target tissue, which could lead to tissue injury, longer and repeat procedures.
View FDA record ↗ - Open, ClassifiedJan 5, 2024
Recanalization systems may be in a manufacturing mode that allows the system to continuously run without the typical 30 second pauses, and 4-minute warning/5-minute restart required messages to indicate the ten-minute maximum catheter use time has been exceeded, which may increase the risk of the device overheating or breaking.
View FDA record ↗
Compliance history
Matched by FEI 2020394.
FDA inspections
3 on file
- No Action Indicated (NAI)Apr 21, 2026
Bioresearch Monitoring
- No Action Indicated (NAI)Mar 8, 2024
Compliance: Devices
- No Action Indicated (NAI)Mar 8, 2024
Postmarket Assurance: Devices
Inspection citations
0 on file
No citations on file for this FEI number.
Compliance actions
0 on file
No warning letters or injunctions on file for this FEI number.
Import refusals
0 on file
No import refusals on file for this FEI number.